Core Viewpoint Orosur Mining Inc. has reported its unaudited financial results for the quarter ending November 30, 2025, highlighting significant operational developments in Colombia and Argentina, alongside a notable increase in cash reserves. Operational Highlights - Infill drilling at the Pepas gold prospect in Colombia is ongoing, aimed at achieving a NI43-101 compliant Mineral Resource Estimate (MRE), expected by the end of January 2026. Drilling results have confirmed the high-grade mineralization of the Pepas deposit [3]. - A large-scale soil geochemical survey at El Cedro, located 10 km south of Pepas, has identified a substantial gold-bearing system with assays exceeding 1g/t Au [3]. - A second porphyry system has been identified south of El Cedro through new geochemical data analysis combined with historical mapping and airborne geophysical data [4]. - In Argentina, the company has acquired a 51% interest in Deseado Dorado S.A.S, which owns the El Pantano Project. A Phase 2 joint venture will lead to 100% ownership upon an additional investment of US$2 million, with a 3,000-meter drill program already underway [4]. - The initial drilling at El Pantano has confirmed the presence of a low sulphidation epithermal mineral system, with further assay results pending [4]. - The company has decided to withdraw from its lithium project in Nigeria to prioritize capital and human resources, with the investment in Nigeria fully impaired as of May 31, 2025 [4]. Financial Highlights - As of November 30, 2025, the company reported a cash balance of US$16,280,000, a significant increase from US$4,877,000 on May 31, 2025 [7]. - The company completed a brokered private placement on October 2, 2025, raising CAD$20 million through the issuance of common shares, which was oversubscribed [7]. - The total assets increased to US$23,593,000 from US$9,489,000, while total liabilities decreased to US$4,884,000 from US$12,858,000 [6]. - The net loss for the period was reported at US$4,543,000, compared to a net income of US$1,870,000 in the same period last year [8].

Core Viewpoint - The completion of the sale of the Products & Healthcare Services (P&HS) segment marks a strategic transformation for Owens & Minor, which is now rebranded as Accendra Health, focusing on home-based care solutions [2][4]. Group 1: Company Transformation - The sale of the P&HS segment to Platinum Equity for $375 million in cash allows the company to concentrate on becoming a leading home-based care platform [4]. - The company aims to support patients with chronic conditions by providing necessary resources for home-based care, enhancing its focus and resilience [2][3]. Group 2: Future Strategy - Accendra Health will focus on its Apria and Byram brands, aligning capital deployment and corporate strategy to foster durable growth and long-term value creation [3]. - The company retains a 5% equity stake in the P&HS segment and preserves tax attributes exceeding $150 million, which may benefit future financial performance [4].

Core Viewpoint - Orosur Mining Inc. has announced the admission of 666,664 common shares following the exercise of options by consultants, bringing the total number of common shares issued to 392,689,176 [1] Group 1 - The company operates as a minerals explorer and developer with projects located in Colombia and Argentina [1] - The admission of shares occurred on December 16, 2025, as part of a previously announced exercise of options [1] - No warrants were exercised during December, resulting in no additional common shares being issued from the company's block listing [1]

Core Insights - Investors in Owens & Minor (OMI) have experienced a significant decline in share value, losing approximately 75% in 2025 due to the company's decision to back off an ill-conceived acquisition [1] Company Performance - The company's stock performance has been severely impacted, reflecting a lack of confidence in its strategic decisions [1] Market Sentiment - The drastic drop in share value indicates a negative market sentiment towards Owens & Minor, suggesting that investors are wary of the company's future prospects [1]

Core Points - Orosur Mining Inc. has issued 666,664 common shares, representing 0.17% of the current issued share capital, following the exercise of options by consultants [1] - The exercise price for the options was C$ 0.06 per share [1] - Omar Gonzalez, the external Chief Financial Officer, exercised 166,666 options and now holds 166,666 common shares, which is 0.04% of the company's issued share capital [1]

Core Insights - Orosur Mining Inc. has reported significant progress in its exploration activities at El Pantano in Argentina and Anzá in Colombia, highlighting the discovery of a low sulphidation epithermal mineral system at El Pantano [1] Group 1: Exploration Activities - The drilling program at El Pantano has yielded assays for five holes, with notable results including PEP067, which returned 83.7 meters at 4.29 grams per tonne (g/t) of gold from surface [1] - Resource modeling and the NI43-101 report process are currently underway for the findings at El Pantano [1] Group 2: Mineral System Confirmation - The initial holes from the El Pantano drilling program have confirmed the presence of a low sulphidation epithermal mineral system, with further assays pending [1]

Group 1 - The sale of the P&HS business is now definitive, although it still requires closure and is subject to FTC review, indicating increased certainty around the transaction [1] - The company has transitioned to a pure-play Patient Direct business, which will allow for a more focused operational strategy and capital allocation [2] - With the constraints from the P&HS business removed, the company can now invest more aggressively in technology, sales, and product categories to accelerate growth [2]

Core Points - Orosur Mining Inc. has announced the posting of the Notice of Annual and Special Meeting to shareholders, which includes the Management Information Circular and proxy forms [1] - The Annual General Meeting (AGM) is scheduled for December 17, 2025, at 12:30 PM GMT in London, UK [1] - The AGM will take place at the offices of SP Angel Corporate Finance LLP, located at Prince Frederick House, 35-39 Maddox Street, London [1]

Core Points - Orosur Mining Inc. has issued 4,358,332 Common Shares, which represents 1.13% of the current issued share capital of the Company [1] - The issuance follows the exercise of 3,123,332 Restricted Stock Units (RSUs) and 1,280,000 options by directors and consultants [1] - All directors will retain their Shares and will not sell them after the exercise [1]

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $697 million, up from just under $687 million in Q3 2024, with a year-to-date revenue of nearly $2.1 billion, reflecting a 3.4% increase [14][15][18] - Adjusted EBITDA for Q3 2025 was $92 million, down from $108 million in Q3 2024, impacted by a one-time revenue benefit from the previous year [16][18] - Adjusted net income per share was $0.25 for Q3 2025, compared to $0.36 in Q3 2024, while year-to-date adjusted net income per share increased to $0.80 from $0.64 [18] Business Line Data and Key Metrics Changes - Year-over-year growth was noted in sleep therapy, ostomy, and urology categories, while diabetes showed flat performance compared to Q3 2024 but improved from Q2 2025 [15][16] - The company is focusing on improving therapy adherence and expanding customer capture across its ecosystem [15] Market Data and Key Metrics Changes - The company is positioned to benefit from the growing prevalence of chronic conditions such as diabetes and sleep apnea, with over 37 million diagnosed with diabetes and an estimated 85 million adults affected by obstructive sleep apnea in the U.S. [8][9] Company Strategy and Development Direction - The company announced a definitive agreement to sell its Products and Healthcare Services segment to Platinum Equity, allowing it to focus on its Patient Direct business and home-based care [5][6] - Future investments will prioritize technology and automation to enhance patient experience and operational efficiency [9][11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the home-based care business and the potential for growth following the divestiture, emphasizing a unified strategic focus [11][22] - The company anticipates a strong 2026, despite a significant customer loss, and plans to manage operational costs and improve cash flow [27][30] Other Important Information - The company expects to incur approximately $40 million in annualized stranded costs from the divestiture [18] - As of September 30, net debt was $2.1 billion, with expectations for slight reduction by year-end [19][20] Q&A Session Summary Question: Durability of trends going into 2026 and selling into the Optum channel - Management indicated that the Optum channel is new and expected to create more opportunities, with guidance for 2026 to be provided closer to year-end [26][27] Question: Outlook for 2026 and free cash flow trends - Management expects decent top-line growth and margin improvement in 2026, with free cash flow trends anticipated to remain stable despite some one-off costs [30][32] Question: Details on preferred provider agreements and filling the Kaiser contract loss - Management noted that it would take less revenue growth to cover the loss of the Kaiser contract due to its low margin nature, and emphasized the importance of preferred provider agreements [37][39] Question: Clarification on cash flow and balance sheet issues - Management explained that cash flow challenges were related to startup costs of a new kitting facility and over-acquired inventory, which are expected to normalize over time [40][42]